Skip to main content
OpenTrials
Completed

NCT Number: NCT02917408

Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital

Retrospective study of all patients diagnosed with primary biliary cholangitis during January 2001 to July 2016 at West China Hospital by review of medical records. The following variables will be retrospectively studied: age, sex, first symptoms, clinical characteristics, pathology, treatment, stage, complications of cirrhosis, other autoimmune diseases and long-term outcome.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

West China Hospital

Chengdu, Sichuan, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Newly diagnosis of PBC at West China Hospital during January 2001 to July 2016.

Exclusion criteria

  • Simultaneously diagnosed of autoimmune hepatitis or primary sclerosing cholangitis.

Treatment and study plan

Primary outcomes

  1. Description of demographics, management patterns (clinical and diagnostic), comorbidities of PBC patients at diagnosis during the past 16 years.

    Time frame: Up to 16 years.

Secondary outcomes

  1. Evaluation of adverse outcome free survival of the PBC cohort during the 16 years.

    Time frame: Up to 16 years.

Sponsors and collaborators

Lead sponsor

Xiaoli Fan

Other

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Sep 28, 2016
Registry last updated
Nov 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.